Chronic myeloid leukemia is determined by a reciprocal translocation between chromosomes 9 and 22, resulting in the formation of the chimeric BCR/Abl protein (hereafter “BCR/Abl”) that functions as a constitutively active tyrosine kinase. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.